Wellington Management Group’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-3,071,865
Closed -$35.4M 2174
2018
Q4
$35.4M Sell
3,071,865
-1,882
-0.1% -$25.1K 0.01% 823
2018
Q3
$62.8M Sell
3,073,747
-90,060
-3% -$1.85M 0.01% 731
2018
Q2
$50.6M Sell
3,163,807
-255,993
-7% -$3.65M 0.01% 789
2018
Q1
$49.1M Hold
3,419,800
0.01% 784
2017
Q4
$46.9M Buy
3,419,800
+892,611
+35% +$16M 0.01% 786
2017
Q3
$47.8M Buy
+2,527,189
New +$54.6M 0.01% 776

Other funds holding NITE

Wellington Management Group's NITE Position: Q1 2019 in Review

Wellington Management Group sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q1 2019, closing a stake of 3,071,865 shares — an estimated $35.4M sold.

Wellington Management Group first reported a position in NITE in Q3 2017 and held it in 6 quarters. The position peaked at $62.8M in Q3 2018. 53 funds tracked by Wall St. Rank hold NITE as of Q1 2019.

  • Wellington Management Group reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q1 2019 after selling out during the quarter.
  • Wellington Management Group sold 3,071,865 Nightstar Therapeutics plc American Depositary Shares shares in Q1 2019, an estimated $35.4M.
  • Wellington Management Group first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2017 and held it in 6 quarters.
  • Wellington Management Group's Nightstar Therapeutics plc American Depositary Shares position peaked at $62.8M in Q3 2018.
  • 53 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q1 2019.

Based on Wellington Management Group's 13F filing for Q1 2019, filed 15 May 2019.